176 related articles for article (PubMed ID: 31002352)
21. Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes.
Hansen AK; Figenschau Y; Zubiaurre-Martinez I
BMC Musculoskelet Disord; 2017 Nov; 18(1):432. PubMed ID: 29110708
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
23. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.
Pang R; Xu Y; Hu X; Liu B; Yu J
Mol Med Rep; 2020 Nov; 22(5):4135-4142. PubMed ID: 33000217
[TBL] [Abstract][Full Text] [Related]
25. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.
Wierzbicka JM; Binek A; Ahrends T; Nowacka JD; Szydłowska A; Turczyk Ł; Wąsiewicz T; Wierzbicki PM; Sądej R; Tuckey RC; Slominski AT; Chybicki J; Adrych K; Kmieć Z; Żmijewski MA
Int J Oncol; 2015 Sep; 47(3):1084-96. PubMed ID: 26260259
[TBL] [Abstract][Full Text] [Related]
26. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.
Chefetz I; Alvero AB; Holmberg JC; Lebowitz N; Craveiro V; Yang-Hartwich Y; Yin G; Squillace L; Gurrea Soteras M; Aldo P; Mor G
Cell Cycle; 2013 Feb; 12(3):511-21. PubMed ID: 23324344
[TBL] [Abstract][Full Text] [Related]
27. CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.
Slominski AT; Brożyna AA; Kim TK; Elsayed MM; Janjetovic Z; Qayyum S; Slominski RM; Oak ASW; Li C; Podgorska E; Li W; Jetten AM; Tuckey RC; Tang EKY; Elmets C; Athar M
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35775377
[TBL] [Abstract][Full Text] [Related]
28. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
29. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
30. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
31. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
Boyan BD; Sylvia VL; McKinney N; Schwartz Z
J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
[TBL] [Abstract][Full Text] [Related]
32. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
33. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
34. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
[TBL] [Abstract][Full Text] [Related]
35. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
36. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
37. Identification of microRNA expression profiles of CD44
Wang L; Zhi X; Lu Y; Cong Y; Fu Z; Cao J; Xu S; Lv J; Ruan H
Arch Gynecol Obstet; 2022 Aug; 306(2):461-472. PubMed ID: 35076757
[TBL] [Abstract][Full Text] [Related]
38. Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
Pourbagher R; Akhavan-Niaki H; Jorsaraei SGA; Fattahi S; Sabour D; Zabihi E; Abedian Z; Ghasemi M; Golpour M; Mostafazadeh A
Gene; 2020 Apr; 734():144381. PubMed ID: 31978510
[TBL] [Abstract][Full Text] [Related]
39. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
40. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
